1.
Filippo Marino, Francesco Rossi and Emilio Sacco. Mirabegron, a First-in-class Non-antimuscarinic Drug for the Overactive Bladder. NRAMMS-V8 [Internet]. 2023 Oct. 13 [cited 2026 Jul. 21];:48-67. Available from: https://stm.bookpi.org/NRAMMS-V8/article/view/12183